IDEX Corporation Acquires Microfluidics International Corporation
January 11, 2011
IDEX Corporation agreed to acquire Microfluidics International Corporation in an all-cash transaction valued at $1.35 per share, expected to close in Q1 2011. The acquisition adds Microfluidics' Microfluidizer high-shear fluid processors and nanomaterials processing capabilities to IDEX's Fluid and Metering segment to expand its pharmaceutical and particle-processing product offerings.
- Buyers
- IDEX Corporation
- Targets
- Microfluidics International Corporation
- Sellers
- Microfluidics shareholders, Global Strategic Partners, LLC (a wholly-owned subsidiary of Celgene Corporation), Irwin Gruverman (founder), Microfluidics' directors and executive officers
- Industry
- Medical Devices
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
IDEX Corporation Acquires Flow Management Devices, LLC
January 29, 2020
Manufacturing
IDEX Corporation has entered into a definitive agreement to acquire Flow Management Devices, LLC (Flow MD) for $125 million in cash, before closing adjustments. Flow MD, a Phoenix-based maker of small-volume provers used for custody transfer accuracy in the oil and gas industry, has approximately $60 million in annual sales and will join IDEX's energy group.
-
IDEX Corporation Acquires Mott Corporation
July 23, 2024
Manufacturing
IDEX Corporation has entered into and completed a definitive agreement to acquire Mott Corporation for $1.0 billion in cash (approximately $900 million net of present-value tax benefits). The acquisition brings Mott's sintered porous metal filtration and flow-control capabilities into IDEX's Health & Science Technologies segment to expand applied materials capabilities across semiconductor, medical, energy, space & defense, and water purification end markets.
-
IDEX Corporation Acquires Muon Group from Rivean Capital for €700 Million
September 13, 2022
Manufacturing
IDEX Corporation has acquired Muon B.V. and its subsidiaries (Muon Group) from private equity owner Rivean Capital for an enterprise value of €700 million. The Netherlands-based Muon Group, a micro-precision components manufacturer with ~580 employees and ~€140 million of 2022 sales, will join IDEX's Health & Science Technologies segment to expand IDEX's precision-technology capabilities and accelerate product development and customer relationships.
-
Leica Biosystems Acquires Cell IDx
November 8, 2022
Biotechnology
Leica Biosystems has acquired Cell IDx, a San Diego-based leader in multiplexed tissue profiling, integrating Cell IDx's UltraPlex multiplex IHC technology with Leica's BOND RX automation to expand translational research and multiplexing capabilities. The deal advances Leica's research-focused staining and imaging portfolio and brings scale-up and medical/scientific affairs support for Cell IDx customers.
-
IDEX Corporation Acquires Iridian Spectral Technologies
May 22, 2023
Manufacturing
IDEX Corporation agreed to acquire Iridian Spectral Technologies for CAD 150 million and completed the acquisition in May 2023. Iridian, an Ottawa-based designer and manufacturer of thin-film optical filters serving laser communications, telecommunications and life sciences markets, will join IDEX's Optical Technologies within its Health & Science Technology segment to expand IDEX's optical coating and filter capabilities.
-
Cell Microsystems Acquires Fluxion Biosciences
August 23, 2023
Medical Devices
Durham-based Cell Microsystems has acquired Fluxion Biosciences, adding Fluxion's IonFlux, BioFlux and IsoFlux instruments and services to its CellRaft-based product portfolio. The deal is supported by a concurrent Series B financing led by Telegraph Hill Partners to provide growth capital and accelerate product and service integration for cellular analysis and electrophysiology workflows.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.